Proteome Profiling of Muscle Cells and Muscle Tissue Using Stable Isotope Labeling by Amino Acids

  • Emily Canessa
  • Mansi V. Goswami
  • Alison M. Samsel
  • Michael Ogundele
  • Shefa M. Tawalbeh
  • Tchilabalo D. Alayi
  • Yetrib HathoutEmail author
Part of the Methods in Physiology book series (METHPHYS)


Comprehensive and accurate proteome profiling of skeletal muscle remains challenging owing to the large proteome dynamic range in this tissue and the increased sensitivity needed to detect low-abundant proteins. Sarcomeric and glycolytic enzymes are by far the most abundant proteins in muscle, masking detection and quantification of low-abundant proteins such as dystrophin, dystrophin-associated protein complex, cell signaling proteins, and transcription factors. About 5400 unique proteins have been identified so far in skeletal muscle using extensive pre-fractionation methods and mass spectrometry [1]. While this is good for cataloging the muscle proteome, pre-fractionation methods are often not compatible with quantification or comparative proteomics because of inherent technical variability from experiment to experiment leading to false and inaccurate quantification. To overcome these challenges, several stable isotope labeling strategies have been developed and tested in the past in different cell culture models and tissues. Typically, the two samples to be compared are tagged with heavy and light stable isotope-labeled moieties, respectively, either at the peptide level, after digestion of proteins with a protease (e.g., trypsin or endoproteinase Lys-C), or even at the cellular level before protein extraction and processing. This book chapter, we will focus on stable isotope labeling by amino acid in cell culture (SILAC), which is by far the most accurate method for quantitative proteomics in cell culture systems.


  1. 1.
    Gonzalez-Freire, M., Semba, R., Ubaida-Mohien, C., et al. (2016). The human skeletal muscle proteome project: A reappraisal of the current literature. Journal of Cachexia, Sarcopenia and Muscle, 8, 5–18. Scholar
  2. 2.
    Bantscheff, M., Schirle, M., Sweetman, G., et al. (2007). Quantitative mass spectrometry in proteomics: A critical review. Analytical and Bioanalytical Chemistry, 389, 1017–1031. Scholar
  3. 3.
    Ong, S. E., Blagoev, B., Kratchmarova, I., et al. (2002). Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Molecular and Cellular Proteomics, 1(5), 376–386.CrossRefGoogle Scholar
  4. 4.
    Ong, S. E. (2012). The expanding field of SILAC. Analytical and Bioanalytical Chemistry, 404(4), 967–976. Scholar
  5. 5.
    Zhang, A., Williamson, C. D., Wong, D. S., et al. (2011). Quantitative proteomic analyses of human cytomegalovirus-induced restructuring of endoplasmic reticulum-mitochondrial contacts at late times of infection. Molecular and Cellular Proteomics, 10(10), M111.009936. Scholar
  6. 6.
    Mintz, M., Vanderver, A., Brown, K. J., et al. (2008). Time series proteome profiling to study endoplasmic reticulum stress response. Journal of Proteome Research, 7(6), 2435–2444. Scholar
  7. 7.
    Hilger, M., & Mann, M. (2012). Triple SILAC to determine stimulus specific interactions in the Wnt pathway. Journal of Proteome Research, 11(2), 982–994. Scholar
  8. 8.
    Blagoev, B., Kratchmarova, I., Ong, S. E., et al. (2003). A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nature Biotechnology, 21(3), 315–318.CrossRefGoogle Scholar
  9. 9.
    Mann, M. (2006). Functional and quantitative proteomics using SILAC. Nature Reviews Molecular Cell Biology, 7(12), 952–958. Scholar
  10. 10.
    Pimienta, G., Chaerkady, R., & Pandey, A. (2009). SILAC for global phosphoproteomic analysis. Methods in Molecular Biology, 527, 107–116. Scholar
  11. 11.
    Krüger, M., Moser, M., Ussar, S., et al. (2008). SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function. Cell, 134(2), 353–364. Scholar
  12. 12.
    McClatchy, D. B., & Yates, J. R. (2014). Stable isotope labeling in mammals (SILAM). Methods in Molecular Biology, 1156, 133–146. Scholar
  13. 13.
    Zanivan, S., Krueger, M., & Mann, M. (2012). In vivo quantitative proteomics: The SILAC mouse. Methods in Molecular Biology, 757, 435–450. Scholar
  14. 14.
    Zanivan, S., Meves, A., Behrendt, K., et al. (2013). In vivo SILAC-based proteomics reveals phosphoproteome changes during mouse skin carcinogenesis. Cell Reports, 3(2), 552–566. Scholar
  15. 15.
    Moody, L. R., Barrett-Wilt, G. A., Sussman, M. R., et al. (2017). Glial fibrillary acidic protein exhibits altered turnover kinetics in a mouse model of Alexander disease. The Journal of Biological Chemistry, 292(14), 5814–5824. Scholar
  16. 16.
    McClatchy, D. B., Liao, L., Lee, J. H., et al. (2012). Dynamics of subcellular proteomes during brain development. Journal of Proteome Research, 11(4), 2467–2479. Scholar
  17. 17.
    McClatchy, D. B., Liao, L., Park, S. K., Venable, J. D., & Yates, J. R. (2007). Quantification of the synaptosomal proteome of the rat cerebellum during post-natal development. Genome Research, 17(9), 1378–1388.CrossRefGoogle Scholar
  18. 18.
    Savas, J. N., Park, S. K., & Yates, J. R. (2016). Proteomic analysis of protein turnover by metabolic whole rodent pulse-chase isotopic labeling and shotgun mass spectrometry analysis. Methods in Molecular Biology, 1410, 293–304. Scholar
  19. 19.
    Le Bihan, M. C., Barrio-Hernandez, I., Mortensen, T. P., et al. (2015). Cellular proteome dynamics during differentiation of human primary myoblasts. Journal of Proteome Research, 14(8), 3348–3361. Scholar
  20. 20.
    Giudice, J., & Taylor, J. M. (2017). Muscle as a paracrine and endocrine organ. Current Opinion in Pharmacology, 34, 49–55. Scholar
  21. 21.
    Grube, L., Dellen, R., Kruse, F., et al. (2018). Mining the secretome of C2C12 muscle cells: Data dependent experimental approach to analyze protein secretion using label-free quantification and peptide based analysis. Journal of Proteome Research, 17(2), 879–890. Scholar
  22. 22.
    Hartwig, S., Raschke, S., Knebel, B., et al. (2014). Secretome profiling of primary human skeletal muscle cells. Biochimica et Biophysica Acta, 1844(5), 1011–1017. Scholar
  23. 23.
    Le Bihan, M. C., Bigot, A., Jensen, S. S., et al. (2012). In-depth analysis of the secretome identifies three major independent secretory pathways in differentiating human myoblasts. Journal of Proteomics, 77, 344–356. Scholar
  24. 24.
    Duguez, S., Duddy, W., Johnston, H., et al. (2013). Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion. Cellular and Molecular Life Sciences, 70(12), 2159–2174. Scholar
  25. 25.
    Rayavarapu, S., Coley, W., Cakir, E., et al. (2013). Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse. Molecular and Cellular Proteomics, 12(5), 1061–1073. Scholar
  26. 26.
    Vila, M. C., Rayavarapu, S., Hogarth, M. W., et al. (2017). Mitochondria mediate cell membrane repair and contribute to Duchenne muscular dystrophy. Cell Death and Differentiation, 24(2), 330–342. Scholar
  27. 27.
    Vila, M. C., Klimek, M. B., Novak, J. S., Rayavarapu, S., et al. (2015). Elusive sources of variability of dystrophin rescue by exon skipping. Skeletal Muscle, 5, 44. Scholar
  28. 28.
    Shimizu-Motohashi, Y., Komaki, H., Motohashi, N., et al. (2019). Restoring dystrophin expression in duchenne muscular dystrophy: Current status of therapeutic approaches. Journal of Personalized Medicine, 9(1), 1. Scholar
  29. 29.
    Anthony, K., Arechavala-Gomeza, V., Taylor, L. E., et al. (2014). Dystrophin quantification: Biological and translational research implications. Neurology, 83(22), 2062–2069. Scholar
  30. 30.
    Wilson, K., Faelan, C., Patterson-Kane, J. C., et al. (2017). Duchenne and becker muscular dystrophies: A review of animal models, clinical end points, and biomarker quantification. Toxicologic Pathology, 45(7), 961–976. Scholar
  31. 31.
    Brown, K. J., Marathi, R., Fiorillo, A. A., et al. (2012). Accurate quantitation of dystrophin protein in human skeletal muscle using mass spectrometry. Journal of Bioanalysis and Biomedicine, (Supp. 7).
  32. 32.
    Hathout, Y., Marathi, R., Rayavarapu, S., et al. (2014). Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients. Human Molecular Genetics, 23(24), 6458–6469. Scholar
  33. 33.
    Geiger, T., Cox, J., Ostasiewicz, P., et al. (2010). Super-SILAC mix for quantitative proteomics of human tumor tissue. Nature Methods, 7(5), 383–385. Scholar
  34. 34.
    Gilmore, J. M., Milloy, J. A., & Gerber, S. A. (2013). SILAC surrogates: Rescue of quantitative information for orphan analytes in spike-in SILAC experiments. Analytical Chemistry, 85(22), 10812–10819. Scholar
  35. 35.
    Ludwig, C., Gillet, L., Rosenberger, G., et al. (2018). Data-independent acquisition-based SWATH-MS for quantitative proteomics: A tutorial. Molecular Systems Biology, 14(8), e8126. Scholar
  36. 36.
    Lindskog, C., Linné, J., Fagerberg, L., et al. (2015). The human cardiac and skeletal muscle proteomes defined by transcriptomics and antibody-based profiling. BMC Genomics, 16, 475. Scholar
  37. 37.
    Townsend, D. (2014). Finding the sweet spot: Assembly and glycosylation of the dystrophin-associated glycoprotein complex. The Anatomical Record, 297(9), 1694–1705. Scholar
  38. 38.
    Orlando, R. (2012). Quantitative analysis of glycoprotein glycans. Methods in Molecular Biology, 951, 197–215. Scholar

Copyright information

© The American Physiological Society 2019

Authors and Affiliations

  • Emily Canessa
    • 1
  • Mansi V. Goswami
    • 1
  • Alison M. Samsel
    • 1
  • Michael Ogundele
    • 1
  • Shefa M. Tawalbeh
    • 1
  • Tchilabalo D. Alayi
    • 1
  • Yetrib Hathout
    • 1
    Email author
  1. 1.School of Pharmacy and Pharmaceutical SciencesBinghamton University – SUNYJohnson CityUSA

Personalised recommendations